Cimpress (CMPR) Q3 Earnings Miss Estimates, Revenues Up Y/Y

CTAS IRBT CMPR

Cimpress N.V. (CMPR - Free Report) reported third-quarter fiscal 2019 results with GAAP earnings of $6.5 million or 21 cents per share against a loss of $2.3 million or 7 cents per share in the year-ago quarter. Notably, the Zacks Consensus Estimate of earnings was pegged at 42 cents.

Quarter Details

Total revenues for the fiscal third quarter were $661.8 million compared with $636.1 million a year ago. The top line missed the consensus estimate of $665.7 million.

The National Pen segment generated revenues of $79.7 million, down 2.2% year over year. Furthermore, Vistaprint— the largest revenue generating segment of the company — witnessed a decline in revenues. Aggregate quarterly revenues from Vistaprint came in at $349.9 million, down from $357.6 million.

Upload and Print segment’s revenues increased to $188.1 million from $183.8 million due to improved operating metrics. Moreover, revenues from All Other Businesses increased to $50.1 million from $18.9 million.

Gross margin contracted to 48.2% from 49.8% in the year-ago quarter.

Balance Sheet and Cash Flow

As of Mar 31, 2019, Cimpress had $44.3 million in cash and cash equivalents compared with $49.9 million in the prior-year quarter. At the end of the quarter, total debt was $1,075.1 million, up from $812.6 million.

In the fiscal third quarter, Cimpress repurchased 149,382 shares for $12.1 million. Net cash provided by operating activities came in at $17 million against $32.1 million used in the year-ago quarter.

Zacks Rank & Stocks to Consider

Cimpress currently carries a Zacks Rank #5 (Strong Sell).

Some better-ranked stocks in the space are iRobot Corporation (IRBT - Free Report) , Cintas Corporation (CTAS - Free Report) and Actuant Corporation . While iRobot sports a Zacks Rank #1 (Strong Buy), Cintas and Actuant carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

iRobot exceeded estimates in each of the trailing four quarters, the average beat being 94.52%.

Cintas surpassed estimates in each of the trailing four quarters, the average beat being 6.09%.

Actuant surpassed estimates in each of the trailing four quarters, the average beat being 11.01%.

Zacks' Top 10 Stocks for 2019

In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-holds for the year?

Who wouldn't? Our annual Top 10s have beaten the market with amazing regularity. In 2018, while the market dropped -5.2%, the portfolio scored well into double-digits overall with individual stocks rising as high as +61.5%. And from 2012-2017, while the market boomed +126.3, Zacks' Top 10s reached an even more sensational +181.9%.

See Latest Stocks Today >>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>